42.Issue 04 april 21 - INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES

Volume : 08, Issue : 04, April – 2021

Title:

42.A NARRATIVE REVIEW OF DILATED CARDIOMYOPATHY AMONG GENERAL POPULATION

Authors :

Abdulaziz Sultan Abdullah Albaqami,Abdulaziz Mohammed Alotaibi,Amin Fouiz Alsobhi,Ahmed Ofan Aldadi,Salem Hammad Alotaibi,Eman Mohammed Allzez,Sittiy Salama Almalayou,Mushari Fahad Alharbi,Amal Saleh Allhiani,Abdul Rahim Dakhil Allah Al-Thubaiti

Abstract :

This study focuses on some key issues in the medical diagnosis of DCM patients, such as etiology and pathophysiology. A correct diagnosis is critical for avoiding repercussions and receiving appropriate treatment. We searched major biological databases (CINAHL, EMBASE, MEDLINE) for publications on dilated cardiomyopathy management, employing thorough search algorithms for all relevant articles published up to 2018. Dilated cardiomyopathy (DCM) is characterized by ventricular dilatation and dysfunctional contraction. Patients who have been injured have altered systolic function and may or may not develop overt heart failure (HF). In the present, atrial and/or ventricular arrhythmias can exist, and sudden death can occur at any stage of the disease. Dilated cardiomyopathy requires evidence of left ventricle or both ventricular expansion and impaired contraction. If main and secondary causes of heart disease are ruled out by evaluation, which includes a history and physical examination, laboratory tests, and coronary angiography, the disease is called idiopathic.

Cite This Article:

Please cite this article in press Abdulaziz Sultan Abdullah Albaqami et al., A Narrative Review Of Dilated Cardiomyopathy Among General Population., Indo Am. J. P. Sci, 2021; 08(04).

Number of Downloads : 10

References:

1. Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, Duboc D, Gimeno J, de Groote P, Imazio M, Heymans S, Klingel K, Komajda M, Limongelli G, Linhart A, Mogensen J, Moon J, Pieper PG, Seferovic PM, Schueler S, Zamorano JL, Caforio AL, Charron P. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2016;37:1850–1858.
2. Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol 2013;10:531–547.
3. Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, Di Lenarda A, Sinagra G. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail 2014;16:317–324.
4. Merlo M, Pyxaras SA, Pinamonti B, Barbati G, Di Lenarda A, Sinagra G. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol 2011;57:1468–1476.
5. Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK (1984). Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol, 54: 147-152.
6. Haas J, Frese KS, Peil B, Kloos W, Keller A, et al. (2014). Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J , 36: 1123-1135.
7. McNally EM, Golbus JR, Puckelwartz MJ (2013) Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest 123: 19-26.
8. Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, et al. (2006) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296: 1867-1876.
9. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ (1994). Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation, 90: 2772-2779.
10. Belloni E, De Cobelli F, Esposito A, Mellone R, Perseghin G, et al. (2008) MRI of cardiomyopathy. AJR Am J Roentgenol191: 1702-1710.
11. La Vecchia L, Zanolla L, Varotto L, Bonanno C, Spadaro GL (2001). Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction. Am Heart J, 142: 181-189.
12. Gulati A, Ismail TF, Jabbour A, Alpendurada F, Guha K, et al (2013). The prevalence and prognostic significance of right ventricular systolic dysfunction in non-ischemic dilated cardiomyopathy. Circulation, 113, 1-37.
13. Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, et al. (2016). Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J, 37: 1850-1858.
14. Merlo M, Gentile P, Naso P, Sinagra G (2017). The natural history of dilated cardiomyopathy: how has it changed? J Cardiovasc Med (Hagerstown)., 18, e161-e165.
15. McNally EM, Golbus JR, Puckelwartz MJ (2013) Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest 123: 19-26.
16. Sisakian H (2014) Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies. World J Cardiol 6: 478-494.
17. George A, Figueredo VM (2011) Alcoholic cardiomyopathy: a review. J Card Fail 17: 844-849.
18. Caforio AL, Mahon NG, Baig MK, Tona F, Murphy RT, et al. (2007). Prospective assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation115,115:76-83.
19. Hil?ker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs, J (2015). Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J, 36: 1090–1097.
20. Chen YB, Dec GW, Lilly LS. The cardiomyopathies. In: Lilly LS, ed. Pathophysiology of heart disease: a collaborative project of medical students and faculty. New York: Lippincott Williams and Wilkins, 2007.
21. Portig I, Wilke A, Freyland M, et al. Familial inflammatory dilated cardiomyopathy. Eur J Heart Failure 2006;8:816–25.
22. Mestroni L, Maisch B, McKenna WJ, et al. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J 1999;20:93–102.
23. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1980;62:1054–61.
24. Elliott P. Diagnosis and management of dilated cardiomyopathy. Heart 2000;84:106–12.
25. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999;99:1091–100.
26. Mason JW. Techniques for right and left ventricular endomyocardial biopsy. J Cardiol 1978;41:887–92.
27. Luk A, Metawee M, Ahn E, et al. Do clinical diagnoses correlate with pathological diagnosis in cardiac transplant patients? The importance of endomyocardial biopsy. Can J Cardiol. In press.